|
SPTLC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.199990E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.127920E-02 |
| Normal-vs-Stage2 |
1.377420E-01 |
| Normal-vs-Stage3 |
1.469240E-01 |
| Normal-vs-Stage4 |
2.301500E-02 |
| Stage1-vs-Stage2 |
8.108200E-01 |
| Stage1-vs-Stage3 |
8.611600E-01 |
| Stage1-vs-Stage4 |
6.375200E-01 |
| Stage2-vs-Stage3 |
9.407200E-01 |
| Stage2-vs-Stage4 |
4.852400E-01 |
| Stage3-vs-Stage4 |
5.726000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.049510E-02 |
| Normal-vs-AfricanAmerican |
6.693700E-02 |
| Normal-vs-Asian |
1.960600E-01 |
| Caucasian-vs-AfricanAmerican |
7.539200E-01 |
| Caucasian-vs-Asian |
4.380400E-01 |
| AfricanAmerican-vs-Asian |
3.449000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.957200E-03 |
| Normal-vs-Female |
3.611200E-01 |
| Male-vs-Female |
7.909700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.699400E-03 |
| Normal-vs-Extreme_Weight |
4.039600E-03 |
| Normal-vs-Obese |
2.967000E-01 |
| Normal-vs-Extreme_Obese |
8.190200E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.838600E-01 |
| Normal_Weight-vs-Obese |
1.662590E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.536800E-01 |
| Extreme_Weight-vs-Obese |
1.209230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.655400E-01 |
| Obese-vs-Extreme_Obese |
4.703200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.336400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.139000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.040920E-03 |
| Normal-vs-Age(81-100Yrs) |
3.790000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.781000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.020200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.775000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.501900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.474200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.858200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.853900E-02 |
| Normal-VS-Type2 PRCC |
9.807800E-04 |
| Normal-VS-KIRP CIMP |
5.897600E-01 |
| Normal-VS-Unclassified PRCC |
4.700600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.258000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.192600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.804600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.778000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.400300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.347000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204300E-03 |
| Normal-vs-N1 |
7.327800E-02 |
| Normal-vs-N2 |
1.157180E-01 |
| N0-vs-N1 |
4.710200E-01 |
| N0-vs-N2 |
9.511600E-01 |
| N1-vs-N2 |
7.831000E-01 |
|
|
